A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...

Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

On April 13, 2023, the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine will convene a virtual, public workshop to explore the state of the science with ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

Much of pancreatic cancer’s evasive and deadly nature may come down to low levels of one gene. In A Nutshell Early detection, ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...

LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough ...